News Focus
News Focus
icon url

JerryCampbell

11/02/19 2:33 AM

#249849 RE: Kam8 #249848

Consider some more basic questions.

Will there ever be DCVax Direct trials?

If so, when does the Phase II start?

How large is the trial, and how long will it take to recruit?

What are the endpoints?

How long might it take to reach those endpoints?

How much will Direct trials cost, and how will they be funded?

Does the length of the DCVAX-L trial give any indication of Direct trial length?

Might want to solve a few of those before jumping straight to valuation.
icon url

sukus

11/02/19 8:13 AM

#249856 RE: Kam8 #249848

Hi Kam8, I hope Direct can be validated much faster than L. If Direct can convincingly extend the life of stage 4 cancer patients by few months, I believe it will be good start to get approval. So I think those patients with the metastatic cancers are the ones Direct would be validated on. These patients have only few months to live. Pressing needs to try to save them first.